Cogent Biosciences, Inc.
Cogent Biosciences, Inc. (COGT) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
294 institutional managers reported holding COGT in 13F filings for the quarter ended 2026-03-31. 68 opened new positions that quarter. Held by FMR (Fidelity), BlackRock, Vanguard Group, among others. On the short side, 13.5M shares were sold short as of the 2026-06-15 count, about 8% of shares outstanding (5.8 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
Open-market insider buys at COGT over the trailing three years: 2025: 2 buys totaling $25.33M. 7 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
COGT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-09 | +7.3% | -17.8% |
| 2023-11-08 | +3.9% | -27.6% |
| 2024-02-27 | +0.7% | -13.2% |
| 2024-05-08 | +0.4% | +17.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
COGT's latest 8-K filings: 2026-08-10 (items 8.01, 9.01); 2026-08-10 (items 2.02, 9.01); 2026-06-11 (items 5.07); 2026-05-05 (items 2.02, 9.01); 2026-02-17 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.